Researchers from Johns Hopkins University have developed an oral treatment that could soon be used to destroy cancer cells ...
Jefferies London Healthcare Conference 2025 November 18, 2025 8:00 AM ESTCompany ParticipantsSteve Chapman - CEO & ...
A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.
Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...
More young adults are also being diagnosed, according to Yale Medicine and the Cancer Research Institute. According to the ...
A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...
A new study from UC San Diego in La Jolla offers evidence that the class of weight-loss drugs behind Ozempic, Wegovy and Mounjaro may do more than regulate blood sugar and weight — it might improve ...
Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...
OBI-902, targeting TROP2, gains FDA orphan drug status for cholangiocarcinoma, a rare cancer with poor prognosis and limited treatments. Orphan drug designation provides benefits like tax credits and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback